The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical trial assessing ...

Attending the Mahakumbh Mela demands extensive walking and standing, resulting in potential bone and joint pains. Essential tips include wearing comfo ...

If approved, condoliase would be the first biologic or drug green-lit for lumbosacral radicular pain. Patients with this condition have been seeking relief, with varying degrees of success ...